Top 10 US Headlines: Essential News Briefing for Informed Citizens

The United States conducted airstrikes on Iranian military targets near the Strait of Hormuz. Brent crude oil jumped two percent to ninety-six dollars and fifteen cents a barrel. In yesterday's briefing, we tracked the market's anxiety over vague global tensions—today, those tensions have a name and a location, and they are disrupting the world's oil supply. Here are the other developing stories for Wednesday, May twenty-ninth, 2026. Despite the conflict, Wall Street posted cautious gains. The Dow rose a slight point-two percent, with the S&P 500 and Nasdaq also up, as investors weighed the geopolitical risk against expected tech earnings.

CVS Health announced it will reinstate insurance coverage for Eli Lilly’s obesity drug Zepbound, starting October first. The reversal comes after the pharmacy benefit manager dropped the GLP-1 drug from its commercial formularies, citing cost. The number of uninsured Americans is climbing. Approximately eight percent of the country lacked health insurance in 2025, an increase of eight hundred thousand people, including three hundred thousand children. Changes to Medicaid are the primary driver. Former President Donald Trump publicly reaffirmed his support for the cryptocurrency industry, promising a “future-proof” regulatory framework.

He claimed credit for making the US a crypto capital, pointing to firms like HIVE Digital Technologies, which relocated its headquarters from Canada to Texas. Gap Incorporated shares fell fifteen percent in premarket trading. The company cut its full-year sales outlook, blaming weak performance in the women’s dresses category at its Old Navy division. Defense contractor Booz Allen Hamilton lowered its 2026 revenue guidance. The firm cited challenges in its civil sector business, and will sharpen its focus on national security contracts. Home equity loan rates are holding relatively steady. The average rate for a HELOC is seven-point-two-one percent, while a fixed home equity loan is at seven-point-three-six percent.

And President Trump has refiled his ten billion dollar defamation lawsuit against the publisher of The Wall Street Journal. The suit concerns an article about a letter written to financier Jeffrey Epstein. Let’s go back to the Strait of Hormuz. The US airstrikes were not a random escalation. They targeted Iranian drone-launching units. According to US officials, these units were part of a campaign to extort commercial vessels passing through the strait, one of the world's most critical oil chokepoints. Iran’s Persian Gulf Strait Authority was reportedly demanding payments up to two million dollars for safe passage. The US response was twofold: military strikes, and new sanctions against that very authority.

President Trump was blunt, stating, “It’s international waters. The strait’s going to be open to everybody,” and the US will “watch over it.” But with Brent crude nearing one hundred dollars a barrel, the financial cost of "watching over it" is rising daily. A diplomatic accord remains out of reach, caught between Iranian demands and pressure from Republican hawks in Congress. The situation is now a standoff, measured in tanker movements and missile readiness. Meanwhile, a different kind of affordability crisis is playing out at home. CVS Caremark’s decision to put Zepbound back on its formulary is a major reversal. The company says it negotiated directly with Eli Lilly to improve affordability.

Ed DeVaney, the president of CVS Caremark, said, “We acted boldly.” But this bold action is an exception. The broader trend for these expensive GLP-1 drugs is insurers limiting or dropping coverage entirely. This happens as the foundation of American healthcare shows new cracks. The uninsured rate held at about eight percent last year, but the absolute number of people without coverage grew by eight hundred thousand. The cause is clear: the unwinding of pandemic-era Medicaid protections. And it’s about to get worse. The Congressional Budget Office estimates that ten million more Americans could become uninsured over the next decade from Medicaid changes alone.

Add to that the expiration of Affordable Care Act subsidies, which is expected to push another five million people off marketplace plans THIS year. So while one company makes a deal to cover one expensive drug, millions are at risk of losing coverage for everything. Foreign conflicts are driving prices at the pump. Domestic policy is driving people off their insurance plans. The two fronts are now defining the cost of living in America.